Frequently Asked Questions

Conference Speakers

Cultural Speakers

Cultural practices, beliefs, and norms play a very important role not only in delivering health care to clients and patients, but also in how that health care is received and what outcomes are possible. Diversity within those beliefs and practices, and as a result of available resources or social economic/demographic circumstances, must be fully understood in order for health care professionals to provide the best care possible no matter where they are in the world, or what culture they are practicing within.

At GOLD Perinatal Care, we understand the importance of Culture and Diversity in health care, and we are working hard to bring you speakers and presentations from around the world that will help you understand the patients and clients you are working with. Discovering how health care is provided and received in other countries and cultures around the world can have a positive impact on our own professional practice. Given that culture is defined by much more than political borders, GOLD Perinatal Care invites speakers to share their knowledge and expertise about perinatal health care from a geographically-based focus or a people-group focus from within a particular set of beliefs, lifestyle or minority. This year, our Culture and Diversity speakers will be presenting on:

- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Dr. Second Speaker Name
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
View Registration Info
Speakers

Speakers (5191)

Sunday, 08 August 2021 11:21

Antonio Nieto

Written by
Sunday, 08 August 2021 11:21

Rafael Nuñez

Written by
Sunday, 08 August 2021 11:21

Christian Grohé

Written by
Sunday, 08 August 2021 11:21

Ildiko Horvath

Written by
Sunday, 08 August 2021 11:21

M. Eugenia Olmedo

Written by
Sunday, 08 August 2021 11:21

Sophie Cousin

Written by
Sunday, 08 August 2021 11:21

Andrea Fulop

Written by
Sunday, 08 August 2021 11:21

Tony Mok

Written by
Professor Tony S.K. Mok is the Li Shu Fan Medical Foundation endowed professor and chairman of the Department of Clinical Oncology at the Chinese University of Hong Kong. He received his medical degree from the University of Alberta, Canada and then subsequently completed a fellowship in medical oncology at the Princess Margaret Hospital in Toronto, Canada. After working as a community oncologist in Toronto, Canada, he returned to Hong Kong to pursue an academic career.

Professor Mok’s main research interest focuses on biomarker and molecular targeted therapy in lung cancer. He was the principal investigator and first author on the landmark IRESSA® Pan-Asia Study (IPASS), which was the first study that confirmed the application of precision medicine for advanced lung cancer. He has also led and co-led multiple international Phase III studies. He dedicates his work on precision medicine for lung cancer by also engaging in clinical research on oncogene driven lung cancer and immunotherapy. His work has been adopted by multiple international guidelines, including NCCN, AMP/IASLC/CAP, ASCO, and ESMO. He also contributes to the development of clinical research infra-structure in China and Asia. Professor Mok cofounded the Lung Cancer Research Group, Chinese Thoracic Oncology Research Group, and Asia Thoracic Oncology Research Group.

Professor Mok has contributed to over 260 articles in international peer-reviewed journals, including the New England Journal of Medicine, Science, Lancet, Nature Medicine, and Journal of Clinical Oncology, and has published multiple editorials and textbooks. He served as an associate editor for thoracic oncology for the Journal of Clinical Oncology and other international journals. Professor Mok is the past president and past treasurer of the International Association for the Study of Lung Cancer (IASLC) and is active in international education activity. His work has been recognized by numerous awards.
Sunday, 08 August 2021 11:21

Lynne Poole

Written by
Sunday, 08 August 2021 11:21

Xiaojin Shi

Written by
Page 37 of 371